Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-16-132216
Filing Date
2016-11-08
Accepted
2016-11-07 20:12:14
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-1/A v452377_f1a.htm F-1/A 2415971
2 EXHIBIT 10.12 v452377_ex10-12.htm EX-10.12 201909
3 EXHIBIT 23.1 v452377_ex23-1.htm EX-23.1 2857
4 GRAPHIC finlogo.jpg GRAPHIC 4361
5 GRAPHIC logo.jpg GRAPHIC 24464
6 GRAPHIC pg1img1_ex23-1.jpg GRAPHIC 5521
7 GRAPHIC pg85img1.jpg GRAPHIC 72948
  Complete submission text file 0001144204-16-132216.txt   2769966
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-208817 | Film No.: 161979748
SIC: 2834 Pharmaceutical Preparations